Skip to main content
SpringerLink
Log in

Tissue Iron Overload and Mechanisms of Iron-Catalyzed Oxidative Injury

  • Chapter
Book cover Free Radicals in Diagnostic Medicine

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 366))

Abstract

Tissue iron overload causes cell damage and organ dysfunction. The mechanisms of iron uptake by tissues and the probable biochemical pathways of iron-derived tissue injury will be reviewed. The iron-overload states are the initial clinical setting where the contribution of iron-catalyzed oxidative injury to the pathogenesis of a clinical disease has been appreciated. When viewed from the perspective of oxidative injury, the iron-overload syndromes also provide a model of tissue injury that is applicable to other disease states, including inflammation, ischemia-reperfusion injury, and anthracycline-induced cardiac toxicity. The goal of this chapter will be to provide a brief clinical overview of the iron-overload states, review the mechanisms of tissue iron uptake in normal and pathologic situations, the likely cellular targets and reactions of iron-catalyzed oxidative injury, and the clinical therapy of the iron-overload syndromes. The potential role of iron-catalyzed oxidative injury in the myocardial damage resulting from ischemia and reperfusion, and from anthracycline administration will also be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. J.L. Goldstein, M.S. Brown. Genetics and cardiovascular disease, in: Heart Disease A Textbook of Cardiovascular Medicine. E. Braunwald, ed., W.B. Saunders Company Philadelphia, PA. (1988).

    Google Scholar 

  2. D.S. Rosenthal, E. Braunwald. Hematological-oncological disorders and heart disease, in: Heart Disease A Textbook of Cardiovascular Medicine. E. Braunwald, ed., W.B. Saunders Company Philadelphia, PA. (1988).

    Google Scholar 

  3. D.M. Koeller, J.A. Horowitz, J.L. Casey, R.D. Klausner, J.B. Harford, Translation and the stability of mRNAs encoding the transferrin receptor and c-fos, Proc Natl Acad Sci USA 88:7778–7782 (1991).

    Article  PubMed  CAS  Google Scholar 

  4. R.D. Klausner, J.B. Harford, Cis-trans models for post-transcriptional gene regulation. Science 246:870–872 (1989).

    Article  PubMed  CAS  Google Scholar 

  5. P.C. Adams, L.A. Chau, Hepatic ferritin uptake and hepatic iron, Hepatology 11:805–808 (1990).

    Article  PubMed  CAS  Google Scholar 

  6. J.C. Sibille, M. Ciriolo, H. Kondo, R.R. Crichton, P. Aisen, Subcellular localization of ferritin and iron taken up by rat hepatocytes, Biochem J 262:685–688 (1989).

    PubMed  CAS  Google Scholar 

  7. R.A. Floyd, Direct demonstration that ferrous ion complexes of di-and triphosphate nucleotides catalyze hydroxyl free radical formation from hydrogen peroxide. Arch Biochem Biophys 225;263–270 (1983).

    Article  PubMed  CAS  Google Scholar 

  8. R.A. Floyd, C.A. Lewis, Hydroxyl free radical formation from hydrogen peroxide by ferrous iron-nucleotide complexes, Biochemistry 22:2645–2649 (1983).

    Article  PubMed  CAS  Google Scholar 

  9. M. Grootveld, J.D. Bell, B. Halliwell, O.I. Aruoma, A. Bomford, P.J. Sadler, Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy, J Biol Chem, 264:4417–4422 (1989).

    PubMed  CAS  Google Scholar 

  10. G. Link, A. Pinson, C. Hershko, Heart cells in culture: a model of myocardial iron overload and chelation, J Lab Clin Med, 106:147–153 (1985).

    PubMed  CAS  Google Scholar 

  11. J. Kaplan, I. Jordan, A. Sturrock, Regulation of the transferrin-independent iron transport system in cultured cells, J Biol Chem, 266:2997–3004 (1991).

    PubMed  CAS  Google Scholar 

  12. J.G. Parkes, R.A. Hussain, N.F. Olivieri, D.M. Templeton, Effects of iron loading on uptake, speciation, and chelation of iron in cultured myocardial cells, J Lab Clin Med 122:36–47 (1993).

    PubMed  CAS  Google Scholar 

  13. A. Jacobs, Low molecular weight intracellular iron transport compounds. Blood 50:433–439 (1977).

    PubMed  CAS  Google Scholar 

  14. P. Biemond, A.J.G. Swaak, C.M. Beindorff, J.F. Koster JF, Superoxidedependent and-independent mechanisms of iron mobilization from ferritin by xanthine oxidase, Biochem J, 239:169–173 (1986).

    PubMed  CAS  Google Scholar 

  15. G. Healing, J. Gower, B. Fuller, C. Green, Intracellular iron redistribution, an important determinant of reperfusion damage to rabbit kidneys, Biochem Pharm 7:1239–1245 (1990).

    Article  Google Scholar 

  16. S. Holt, M. Gunderson, K. Joyce, N.R. Nayini, G.F. Eyster, A.M. Garitano, C Zonia, G.S. Krause, S.D. Aust, B.C. White, Myocardial tissue iron derealization and evidence for lipid peroxidation after two hours of ischemia, Ann Emerg Med 15:1155–1159 (1986).

    Article  PubMed  CAS  Google Scholar 

  17. S. Harel, M.A. Salan, J. Kanner, Iron release from methyoclobin, methemoglobin and cytochrome c by a system generating hydrogen peroxide, Free Rad Res Comms 5:11–19 (1988).

    Article  CAS  Google Scholar 

  18. S. Harel, J. Kanner, The generation of ferryl or hydroxyl radicals during interaction of haemproteins with hydrogen peroxide, Free Rad Res Comms 5:21–33 (1988).

    Article  CAS  Google Scholar 

  19. J.K. Brieland, J.C. Fantone, Ferrous iron release from transferrin by hemin neutrophil-derived superoxide anion: effect of pH and iron saturation. Arch Biochem Biophys 284:78–83 (1991).

    Article  PubMed  CAS  Google Scholar 

  20. J.K. Brieland, S.J. Clarke, S. Karminol, S.H. Phan, J.C. Fantone, Transferrin: a potential source of iron for oxygen free radical-mediated endothelial cell injury, Arch Biochem Biophys 294:265–270 (1992).

    Article  PubMed  CAS  Google Scholar 

  21. B. Halliwell, J.M.C. Gutteridge, Oxygen toxicity, oxygen radicals, transition metals and disease, Biochem J 219:1–14 (1984).

    PubMed  CAS  Google Scholar 

  22. B. Halliwell, J.M.C. Gutteridge, Oxygen free radical and iron in relation to biology and medicine: Some problems and concepts, Arch Biochem Biophys 246:501–514 (1986).

    Article  PubMed  CAS  Google Scholar 

  23. E. Graf, J.R. Mahoney, R.G. Bryant, J.W. Eaton, Iron-catalyzed hydroxyl radical formation, J Biol Chem 259:3620–3624 (1984).

    PubMed  CAS  Google Scholar 

  24. L.A. Loeb, E.A. James, A.M. Waltersdorph, S.J. Klebanoff, Mutagenesis by the autoxidation of iron with isolated DNA, Proc Natl Acad Sci USA 85:3918–3922 (1988).

    Article  PubMed  CAS  Google Scholar 

  25. H.W. Gardner, Oxygen radical chemistry of polyunsaturated fatty acids, Free Rad Biol Med 7:65–86 (1989).

    Article  PubMed  CAS  Google Scholar 

  26. E.R. Stadtman, Metal ion-catalyzed oxidation of proteins: Biochemical mechanism and biological consequences Free Rad. Biol. Med 9:315–325 (1990).

    Article  PubMed  CAS  Google Scholar 

  27. F.Z. Meerson, V.E. Kagan, N.P. Kozlov, L.M. Belkina, Y.V. Arkhipenko, The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of heart, Basic Res Cardiol 77:465–485 (1982).

    Article  PubMed  CAS  Google Scholar 

  28. E.J. Lesnefsky, K.G.D. Allen, F.P. Carrea, L.D. Horwitz, Iron-Catalyzed Lipid Peroxidation Occurs in the Intact Heart: Detection Using a New Lipid Peroxide Assay, J Mol Cell Cardiol 24:1031–1038 (1992).

    Article  PubMed  CAS  Google Scholar 

  29. K.P. Burton, J.M. McCord, G. Ghai, Myocardial alteration due to free radical generation. Am J Physiol 246:H776–H783 (1984).

    PubMed  CAS  Google Scholar 

  30. J.M. Braughler, L.A. Duncan, R.L. Chase, The involvement of iron in lipid peroxidation, J Biol Chem 261:10282–10289 (1986).

    PubMed  CAS  Google Scholar 

  31. J.M. Gutteridge, The role of superoxide and hydroxyl radicals in phospholipid peroxidation catalyzed by iron salts, FEBS Lett 150:454–458 (1982).

    Article  PubMed  CAS  Google Scholar 

  32. J.R. Bucher, M. Tien, S.D. Aust, The requirement for ferric in the initiation of lipid peroxidation by chelated ferrous iron, Biochem Biophys Res Comm 111:777–784 (1983).

    Article  PubMed  CAS  Google Scholar 

  33. J.M.C. Gutteridge, Lipid peroxidation initiated by superoxide-dependent hydroxyl radicals using complexed iron and hydrogen peroxide. FEBS Lett 172:245–249 (1984).

    Article  PubMed  CAS  Google Scholar 

  34. P.J. O’Brien, Intracellular mechanisms for the decomposition of a lipid peroxide. I. Decomposition of a lipid peroxide by metal ions, heme compounds, and nucleophiles, Can J Biochem 47:485–499 (1969).

    Article  PubMed  Google Scholar 

  35. B.A. Svinson, J.A. Buege, F.O. O’Neal, S.D. Aust, The mechanism of NADPH-dependent lipid peroxidation, J Biol Chem 254:5892–5899 (1979).

    Google Scholar 

  36. J.M. Gutteridge, R. Richmond, B. Halliwell, Inhibition of the iron-catalyzed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxamine, Biochem J 184:469–472 (1979).

    PubMed  CAS  Google Scholar 

  37. G. Cohen, P.M. Sinet, The Fenton reaction between ferrous-diethylene triamepenta-acetic acid and hydrogen peroxide. FEBS Lett 138:258–260 (1982).

    Article  CAS  Google Scholar 

  38. B.R. Bacon, R. O’Neill, Park C.H., Iron-induced peroxidative injury to isolated rat hepatic mitochondria. Free Rad Biol Med 2:339–347 (1986).

    Article  CAS  Google Scholar 

  39. B.R. Bacon, C.H. Park, G.M. Brittenham, R. O’Neil, A.S. Tavill, Hepatic mitochondrial oxidative metabolism in rats with chronic dietary iron overload, Hepatology 5:789–797 (1985).

    Article  PubMed  CAS  Google Scholar 

  40. A. Masini, D. Ceccareli, T. Trenti, F.P. Corongiu, U. Muscatello, Perturbation in liver mitochondrial Ca2+homeostasis in experimental iron overload: a possible factor in cell injury, Biochim Biophys Acta 1014:133–140 (1989).

    Article  PubMed  CAS  Google Scholar 

  41. G. Link, A. Pinson, Hershko C., Iron loading of cultured cardiac myocytes modifies sarcolemmal structure and increases lysosomal fragility. J Lab Clin Med 121:127–134 (1993).

    PubMed  CAS  Google Scholar 

  42. I.T. Mak, W.B. Weglicki, Characterization of iron-mediated peroxidative injury in isolated hepatic lysosomes, I Clin Invest 75:58–63 (1985).

    Article  CAS  Google Scholar 

  43. K. Houglum, M. Filip, J.L. Witzutum, M. Choikier, Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload, J Clin Invest 86:1991–1998 (1990).

    Article  PubMed  CAS  Google Scholar 

  44. C.A. Seymour, T.J. Peters, Organelle pathology in primary and secondary haemochromatosis with special reference to lysosomal changes, Br I Haematol 40:239–253 (1978).

    Article  CAS  Google Scholar 

  45. M.P. Weir, J.F. Gibson, T.J. Peters, Haemodiserin and tissue damage, Cell Biochem Fund 2:186–194 (1984).

    Article  CAS  Google Scholar 

  46. A.D. Heys, T.L. Dormandy, Lipid peroxidation in iron loaded spleens, Clin Sci 60:295–301 (1981).

    PubMed  CAS  Google Scholar 

  47. L. Wolfe, N. Olivieri, D. Sallan, Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major, New Engl J Med 312:1600–1603 (1985).

    Article  PubMed  CAS  Google Scholar 

  48. A. Cohen, Current status of iron chelation therapy with deferoxamine, Semin Hematol 27:86–90 (1990).

    PubMed  CAS  Google Scholar 

  49. R. Marcus, S. Davies, H. Bantock, S. Underwood, S. Walton, E. Huehns, Desferrioxamine to improve cardiac function in iron-overloaded patients with thalassemia major, Lancet 1:392–393 (1984).

    Article  PubMed  CAS  Google Scholar 

  50. S. Hoe, D.A. Rowley, B. Halliwell, Reactions of ferrioxamine and desferrioxamine with the hydroxyl radical, Chem Biol Inter 41:75–81 (1982).

    Article  CAS  Google Scholar 

  51. E.J. Lesnefsky, J.E. Repine, L.D. Horwitz, Deferoxamine pretreatment reduces canine infarct size and oxidative injury, J Pharm Exp Ther 253:1103–1109 (1990).

    CAS  Google Scholar 

  52. R. Laub, Y.J. Schneider, J.N. Octave, A. Trouet, R.R. Crichton, Cellular pharmacology of deferoxamine B and derivatives in cultured rat hepatocytes in relation to iron mobilization, Biochem Pharm 34:1175–1183 (1985).

    Article  PubMed  CAS  Google Scholar 

  53. D.E. Gannon, J. Varani, S.H. Phan, J.H. Ward, J. Kaplan, G.O. Till, R.H. Simon, U.S. Ryan, P.A. Ward, Source of iron in neutrophil-mediated killing of endothelial cells, Lab Invest 57:37–44 (1987).

    PubMed  CAS  Google Scholar 

  54. G.J. Kontoghiorghes, The study of iron mobilisation from transferrin using aketohydroxy heteroaromatic chelators, Biochim Biophys Acta 869:141–146 (1986).

    Article  PubMed  CAS  Google Scholar 

  55. J.B. Porter, M. Gyparaki, L.C. Burke, E.R. Huehns, P. Sarpong, V. Saez, R.C. Hider, Iron mobilization from hepatocyte monolayer cultures by chelators: the importance of membrane permeability and the ironbinding constant, Blood 72:1497–1503 (1988).

    PubMed  CAS  Google Scholar 

  56. P. Tondury, G.J. Kontoghiorghes, A. Ridolfi-Luthy, A. Hirt, A.V. Hoffbrand, AM. Lottenbach, T. Sonderegger, H.P. Wagner, L1 (l,2-dimethyl-3-hydroxypyrid-4-one) for oral iron chelation in patients with betsthalassemia major, Br J Haematol 76:550–553 (1990).

    Article  PubMed  CAS  Google Scholar 

  57. N.R. Olivieri, G. Koren, C. Hermann, Y. Bentur, D. Chung, J. Lkein, P. St. Louis, M.H. Freedman, R.A. McClelland, D.M. Templeton, Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients, Lancet 336:1275–1279 (1990).

    Article  PubMed  CAS  Google Scholar 

  58. G.J. Kontoghorgies, A. Piga, A.V. Hoffbrand, Cytotoxic and DNA-inhibitory effects of iron chelators on human leukaemic cell lines. Hematol Oncol 4:195–204 (1986).

    Article  Google Scholar 

  59. J.L. Sullivan, The iron paradigm of ischemic heart disease, Am Heart J 117:1177–1188 (1989).

    Article  PubMed  CAS  Google Scholar 

  60. J.T. Salonen, K. Nyyssonen, H. Koppela, J. Tuomilehto, R. Seppanen, R. Salonen, High stored iron levels are associated with excess risk of myocardial infarction in Finnish men. Circulation 86:803–811 (1992).

    Article  PubMed  CAS  Google Scholar 

  61. R.E. Williams, J.L. Zweier, J.T. Flaherty, Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts, Circulation 83:1006–1014 (1991).

    Article  PubMed  CAS  Google Scholar 

  62. A.M.M. van der Kraaij, H.G. van Eijk, J.F. Koster, Prevention of postischemic cardiac injury by the orally active iron chelator 1,2-dimethyl-3-hydroxy-4-pyridone (L1) and the antioxidant ( + )-cyanidanol-3, Circulation 80:158–164 (1989).

    Article  PubMed  Google Scholar 

  63. B.R. Reddy, R.A. Kloner, K. Przyklenk, Early treatment with deferoxamine limits myocardial ischemic/reperfusion injury, Free Rad Biol Med 7:45–52 (1989).

    Article  PubMed  CAS  Google Scholar 

  64. E.J. Lesnefsky, J. Ye, Exogenous Intracellular, But Not Extracellular, Iron Augments Myocardial Oxidative Injury During Ischemia and Reperfusion, Am J Physiol (1994).

    Google Scholar 

  65. E.J. Lesnefsky, J. Ye, Excess Intracellular, But Not Extracellular Iron Augments Myocardial Lipid Peroxidation and Injury During Reperfusion. Clin Res 39:691A (1991).

    Google Scholar 

  66. R. Engler, E. Gilpin, Can superoxide dismutase alter myocardial infarct size? Circulation 79:1137–1142 (1989).

    Article  PubMed  CAS  Google Scholar 

  67. F.P. Carrea, E.J. Lesnefsky, J.E. Repine, R.H. Shikes, L.D. Horwitz, Reduction of Canine Myocardial Infarct Size by a Diffusible Reactive Oxygen Metabolite Scavenger: Efficacy of Dimethylthiourea Given at the Onset of Reperfusion, Circ Res 68:1652–1659 (1991).

    Article  PubMed  CAS  Google Scholar 

  68. S.E. Mitsos, T.E. Askew, J.C. Fantone, S.L. Kunkel, G.D. Abrams, A. Schork, B.R. Lucchesi, Protective effects of N-2-mercaptopropionyl glycine against myocardial reperfusion injury after neutrophil depletion in the dog: evidence for the role of intracellular-derived free radicals, Circulation 73:1077–1086 (1986).

    Article  PubMed  CAS  Google Scholar 

  69. E.J. Lesnefsky, Reduction of Infarct Size by Cell Permeable Oxygen Metabolite Scavengers. Free Rad Biol and Med 12:429–446 (1992).

    Article  CAS  Google Scholar 

  70. R.C. Young, R.F. Ozols, C.E. Myers, The anthracycline antineoplastic drugs. N Engl J Med 305:139–153 (1981).

    Article  PubMed  CAS  Google Scholar 

  71. C.E. Myers, W.P. McGuire, R.H. Liss, Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science 197:165–167 (1977).

    Article  PubMed  CAS  Google Scholar 

  72. P.K. Singal, G.N. Pierce, Adriamycin stimulates low affinity Ca2+ binding and lipid peroxidation but depresses myocardial function. Am J Physiol 250:H419–H425 (1986).

    PubMed  CAS  Google Scholar 

  73. C. Hershko, G. Link, M. Tzahor, J.P. Kaltwasser, P. Athias, A. Grynberg, A. Pinson. Anthracycline toxicity is potentiated by iron and inhibited deferoxamine: Studies in rat heart cells in culture. J Lab Clin Med 122:245–251 (1993).

    PubMed  CAS  Google Scholar 

  74. J.L. Speyer, M.D. Green, A. Zeleneiuch-Jacquotte, J.C. Wernz, M. Rey, J. Sanger, E. Kramer, V. Ferrans, H. Hochster, M. Meyers, et al, ICRF-187 permits longer treatment with doxorubicin in women with breast cancer. J Clin Oncol 10:117–127 (1992).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Cleveland VA Medical Center, Case Western Reserve University, Cleveland, OH, 44106, USA

    Edward J. Lesnefsky

Authors
  1. Edward J. Lesnefsky
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. State University of New York at Buffalo, Buffalo, New York, USA

    Donald Armstrong

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lesnefsky, E.J. (1994). Tissue Iron Overload and Mechanisms of Iron-Catalyzed Oxidative Injury. In: Armstrong, D. (eds) Free Radicals in Diagnostic Medicine. Advances in Experimental Medicine and Biology, vol 366. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1833-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1833-4_10

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5742-1

  • Online ISBN: 978-1-4615-1833-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation